Blood group A antigen pentasaccharide type 1—a key carbohydrate molecule for biomedical research and development CAS 50624-46-9

Blood group A antigen pentasaccharide type 1 (A-Pentasaccharide) is the core oligosaccharide structure of type A antigen in the human ABO blood group system and is known as the "cell surface immune recognition code". It is not only a key chemical basis for determining blood type specificity, but also a highly valuable precision tool molecule in the fields of modern immunology, vaccine development, targeted therapy and disease diagnosis.

Chemical Information

Chemical name: Type A blood antigen pentasaccharide (α-L-Fuc-(1→2)-[α-GalNAc-(1→3)]-β-D-Gal-(1→3/4)-β-D-GlcNAc-(1→3/6)-β-D-Gal)

Common name: Blood group A antigen pentasaccharide type 1; A-Pentasaccharide

Chemical formula: C₃₂H₅₅NO₂₄

Molecular weight: 837.77 g/mol

CAS number: 50624-46-9

Structural features

Blood group A antigen pentasaccharide type 1 is the determinant of ABO blood group A antigen. Its structure is highly specific and biologically important:

Precise sugar chain structure: This pentasaccharide is composed of fucose (Fuc), N-acetylgalactosamine (GalNAc), galactose (Gal) and N-acetylglucosamine (GlcNAc) connected in sequence through specific α- or β-glycosidic bonds. Among them, α-1,2-linked fucose and α-1,3-linked N-acetylgalactosamine are the keys to distinguish A antigen from B antigen (Galα1,3) and O antigen (Fuc only).

Terminal immune determinant: GalNAcα1-3 located at the non-reducing end is the immunodominant structure of the A antigen, which is specifically recognized by the human immune system and is the direct molecular basis for the production of anti-B antibodies.

Natural connection with cell membrane: In the body, this pentasaccharide is usually covalently bonded to lipids (to form glycosphingolipids) or proteins (to form glycoproteins) through the galactose at the reducing end, and is anchored on the surface of red blood cells and other cells to form a histocompatibility antigen.

Main applications and advantages

1. Key reagents for blood type matching and transfusion medicine research

Safe blood transfusion research: used to develop highly sensitive blood type detection reagents, adsorbents and neutralizing reagents to eliminate antibody interference and improve the accuracy and safety of blood transfusion compatibility testing.

Rare blood type research: As a standard, it is used to study and identify A subtypes (such as A₁, A₂, etc.) and other variants, providing molecular basis for the construction of rare blood type libraries.

Organ transplant matching: ABO blood group antigen is one of the major obstacles to solid organ transplantation. The molecule could be used to study strategies to overcome blood group incompatible transplants, such as enzymatically clearing A/B antigens from the graft surface.

2. Molecular tools for infectious diseases and vaccine development

Research on pathogen adsorption mechanism: Many pathogens (such as norovirus, Helicobacter pylori) achieve infection by specifically binding to blood group antigens on the surface of host cells. This pentasaccharide is an ideal tool to study its infection mechanism and develop inhibitors.

Anti-idiotypic vaccine design: Using the A antigen pentasaccharide mimotope, it is possible to design vaccines against specific pathogens whose receptors mimic blood group antigens, or to develop therapeutic vaccines aimed at inducing immune tolerance.

Glycoconjugate vaccine carrier: As a clear oligosaccharide antigen, it can be covalently linked to a carrier protein (such as CRM₁₉₇, TT) and used to prepare highly immunogenic synthetic sugar vaccines to prevent bacterial or viral infections that rely on blood group antigen binding.

3. New targets for cancer diagnosis and targeted therapy

Tumor markers: A variety of adenocarcinoma (such as gastric cancer, colon cancer, pancreatic cancer) cells abnormally express or overexpress A antigen, which is related to tumor metastasis and poor prognosis. This pentasaccharide can be used as a standard for the development of serological or imaging diagnostic tools.

Targeted drug design: Based on the specific expression of A antigen on specific tumor cells, this molecule can be used to construct the targeting headgroup of antibodies (such as monoclonal antibodies, double antibodies), CAR-T cells, antibody drug conjugates (ADCs) or nanomedicines to achieve precise drug delivery.

Research on immune checkpoint regulation: Glycosylation modifications (including ABO antigen expression) in the tumor microenvironment affect immune cell function. This molecule can be used to explore sugar-immune checkpoint interactions and develop new immunotherapies.

4. Core probes for basic immunology and glycobiology research

Antibody-antigen interaction research: As a clear antigenic determinant, it is used to quantitatively analyze the affinity, specificity and dynamics of anti-A antibodies and study the molecular basis of B cell immune response.

Glycosyltransferase functional analysis: It is the final product of the catalytic reaction of type A glycosyltransferase (GTA) and can be used for enzyme activity determination, inhibitor screening and enzyme kinetics research.

Cell recognition and signaling: Study how the pentasaccharide is recognized by receptors such as lectins and selectins, and its signaling role in cell adhesion, inflammatory response, cell differentiation and other processes.

5. Application of biomaterials and cell engineering

Cell surface engineering: Using chemical or enzymatic methods, the A antigen pentasaccharide is displayed on the surface of stem cells, immune cells or engineered cells to regulate their homing, immune recognition or enhance their targeting.

Tissue engineering and biomimetic materials: Integrating A antigen onto the surface of biomaterials can simulate the phenotype of specific cell types (such as vascular endothelial cells) and be used to construct bioactive scaffold materials.

Conclusion

The blood group A antigen pentasaccharide type 1 is much more than one blood group determining molecule. It is the key to decoding cell surface communication language and a bridge connecting glycochemistry, immunology and clinical medicine. From improving the safety of blood transfusions to developing new vaccines, from precision anti-cancer to deciphering intercellular dialogue, its application areas are constantly expanding with the development of glycoscience.

The above information is provided by the editor of KASONS and is for scientific research only.